US 10808225
Use of PDL1 expressing cells to convert T cells into regulatory T cells
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 10808225 (Use of PDL1 expressing cells to convert T cells into regulatory T cells) held by The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/22